Kristin A. Lambert
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kristin A. Lambert has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Faoud T. Ishmael
Pennsylvania State University, College of Medicine University Park, 1850 East Park Avenue, State College, PA 16803, USA
3 shared publications - Man-Hsun Hsu
Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pa
3 shared publications - Faoud T. Ishmael
Penn State College of Medicine
2 shared publications - Ronaldo Paolo Panganiban
Division of Gastroenterology and Hepatology, Department of Medicine, The Pennsylvania State University, Hershey, PA 17033, USA
2 shared publications A.K. Pathak
Center for Infectious Disease Dynamics and Department of Biology, The Pennsylvania State University,University ParkPA16802,USA
1 shared publicationAlanna N Roff
Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, The Pennsylvania State University Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States of America
1 shared publication
Latest Publications
- 1 March 2020
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 124 (3) , 231-232
Promotion of early-career discernment by an allergy and immunology medical student interest group
- 1 March 2020
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 124 (3) , 231-232
Promotion of early-career discernment by an allergy and immunology medical student interest group
- 1 July 2019
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 144 (1) , 315-317
Dust mite induces leukocyte exosomes with proinflammatory effects toward airway epithelial cells
- 1 July 2019
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 144 (1) , 315-317
Dust mite induces leukocyte exosomes with proinflammatory effects toward airway epithelial cells
- Open Access
- 9 October 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (10) , e0205434
MicroRNA-146a is induced by inflammatory stimuli in airway epithelial cells and augments the anti-inflammatory effects of glucocorticoids
MicroRNAs (miRNAs) are emerging as central regulators of inflammation, but their role in asthma and airway epithelial cells is not well studied. Glucocorticoids are the cornerstone of therapy in asthma and other inflammatory disease, yet their mechanisms of action are not completely elucidated, and it is not clear whether miRNAs modulate their effects. We aimed to identify miRNAs that regulate cytokine and chemokine expression in airway epithelial cells and whether these miRNAs are subject to the effects of glucocorticoids. MicroRNAomic analyses of immortalized, normal human bronchial epithelial cells identified 7 miRNAs that were altered by inflammatory cytokine treatment and 22 that were regulated by glucocorticoids (n = 3 for each treatment condition). MiR-146a emerged as a central candidate, whose expression was induced by TNF-α and repressed by glucocorticoids. Its role as a candidate in asthmatic inflammation was supported by expression profiling in human asthmatics, which showed that plasma miR-146a expression was elevated in asthma and associated with measures related to worse asthma outcomes, including elevated blood eosinophil counts, higher asthma control questionnaire scores, and need for higher doses of inhaled glucocorticoids. However, transfection of miR-146a in A549 cells treated with TNF-α +/- glucocorticoids produced an anti-inflammatory effect and increased efficacy of glucocorticoids. We propose a model whereby miR-146a is induced by inflammatory conditions as a feedback mechanism to limit inflammation. Exogenous administration of miR-146a augmented the effects of glucocorticoids and could be a novel therapeutic strategy to enhance efficacy of these medications.
- 9 October 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (10) , e0205434
Open AccessMicroRNA-146a is induced by inflammatory stimuli in airway epithelial cells and augments the anti-inflammatory effects of glucocorticoids
MicroRNAs (miRNAs) are emerging as central regulators of inflammation, but their role in asthma and airway epithelial cells is not well studied. Glucocorticoids are the cornerstone of therapy in asthma and other inflammatory disease, yet their mechanisms of action are not completely elucidated, and it is not clear whether miRNAs modulate their effects. We aimed to identify miRNAs that regulate cytokine and chemokine expression in airway epithelial cells and whether these miRNAs are subject to the effects of glucocorticoids. MicroRNAomic analyses of immortalized, normal human bronchial epithelial cells identified 7 miRNAs that were altered by inflammatory cytokine treatment and 22 that were regulated by glucocorticoids (n = 3 for each treatment condition). MiR-146a emerged as a central candidate, whose expression was induced by TNF-α and repressed by glucocorticoids. Its role as a candidate in asthmatic inflammation was supported by expression profiling in human asthmatics, which showed that plasma miR-146a expression was elevated in asthma and associated with measures related to worse asthma outcomes, including elevated blood eosinophil counts, higher asthma control questionnaire scores, and need for higher doses of inhaled glucocorticoids. However, transfection of miR-146a in A549 cells treated with TNF-α +/- glucocorticoids produced an anti-inflammatory effect and increased efficacy of glucocorticoids. We propose a model whereby miR-146a is induced by inflammatory conditions as a feedback mechanism to limit inflammation. Exogenous administration of miR-146a augmented the effects of glucocorticoids and could be a novel therapeutic strategy to enhance efficacy of these medications.
- Open Access
- 8 August 2018
- Published by OAE Publishing Inc.
Biomarkers and therapeutic targets: microRNA roles in the pathophysiology, diagnosis and management of eosinophilic esophagitis
Keywords: Eosinophilic esophagitis, microRNA, miR-375, miR-21, miR-223, biomarkers, miRNA replacement therapy
- 8 August 2018
- Published by OAE Publishing Inc.
Open AccessBiomarkers and therapeutic targets: microRNA roles in the pathophysiology, diagnosis and management of eosinophilic esophagitis
Keywords: Eosinophilic esophagitis, microRNA, miR-375, miR-21, miR-223, biomarkers, miRNA replacement therapy
- Open Access
- 1 August 2018
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 201 (3) , 916-929
miR-155 Modulates Cockroach Allergen– and Oxidative Stress–Induced Cyclooxygenase-2 in Asthma
Exposure to cockroach allergen is a strong risk factor for developing asthma. Asthma has been associated with allergen-induced airway epithelial damage and heightened oxidant stress. In this study, we investigated cockroach allergen–induced oxidative stress in airway epithelium and its underlying mechanisms. We found that cockroach extract (CRE) could induce reactive oxygen species (ROS) production, particularly mitochondrial-derived ROS, in human bronchial epithelial cells. We then used the RT2 Profiler PCR array and identified that cyclooxygenase-2 (COX-2) was the most significantly upregulated gene related to CRE-induced oxidative stress. miR-155, predicted to target COX-2, was increased in CRE-treated human bronchial epithelial cells, and was showed to regulate COX-2 expression. Moreover, miR-155 can bind COX-2, induce COX-2 reporter activity, and maintain mRNA stability. Furthermore, CRE-treated miR-155−/− mice showed reduced levels of ROS and COX-2 expression in lung tissues and PGE2 in bronchoalveolar lavage fluid compared with wild-type mice. These miR-155−/− mice also showed reduced lung inflammation and Th2/Th17 cytokines. In contrast, when miR-155−/− mice were transfected with adeno-associated virus carrying miR-155, the phenotypic changes in CRE-treated miR-155−/− mice were remarkably reversed, including ROS, COX-2 expression, lung inflammation, and Th2/Th17 cytokines. Importantly, plasma miR-155 levels were elevated in severe asthmatics when compared with nonasthmatics or mild-to-moderate asthmatics. These increased plasma miR-155 levels were also observed in asthmatics with cockroach allergy compared with those without cockroach allergy. Collectively, these findings suggest that COX-2 is a major gene related to cockroach allergen–induced oxidative stress and highlight a novel role of miR-155 in regulating the ROS–COX-2 axis in asthma.
- 1 August 2018
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 201 (3) , 916-929
Open AccessmiR-155 Modulates Cockroach Allergen– and Oxidative Stress–Induced Cyclooxygenase-2 in Asthma
Exposure to cockroach allergen is a strong risk factor for developing asthma. Asthma has been associated with allergen-induced airway epithelial damage and heightened oxidant stress. In this study, we investigated cockroach allergen–induced oxidative stress in airway epithelium and its underlying mechanisms. We found that cockroach extract (CRE) could induce reactive oxygen species (ROS) production, particularly mitochondrial-derived ROS, in human bronchial epithelial cells. We then used the RT2 Profiler PCR array and identified that cyclooxygenase-2 (COX-2) was the most significantly upregulated gene related to CRE-induced oxidative stress. miR-155, predicted to target COX-2, was increased in CRE-treated human bronchial epithelial cells, and was showed to regulate COX-2 expression. Moreover, miR-155 can bind COX-2, induce COX-2 reporter activity, and maintain mRNA stability. Furthermore, CRE-treated miR-155−/− mice showed reduced levels of ROS and COX-2 expression in lung tissues and PGE2 in bronchoalveolar lavage fluid compared with wild-type mice. These miR-155−/− mice also showed reduced lung inflammation and Th2/Th17 cytokines. In contrast, when miR-155−/− mice were transfected with adeno-associated virus carrying miR-155, the phenotypic changes in CRE-treated miR-155−/− mice were remarkably reversed, including ROS, COX-2 expression, lung inflammation, and Th2/Th17 cytokines. Importantly, plasma miR-155 levels were elevated in severe asthmatics when compared with nonasthmatics or mild-to-moderate asthmatics. These increased plasma miR-155 levels were also observed in asthmatics with cockroach allergy compared with those without cockroach allergy. Collectively, these findings suggest that COX-2 is a major gene related to cockroach allergen–induced oxidative stress and highlight a novel role of miR-155 in regulating the ROS–COX-2 axis in asthma.
- 1 January 2018
- Vol. 7 (4) , 57-+
Effects of allergic stimulation and glucocorticoids on miR-155 in CD4+ T-cells
Rationale: MicroRNAs (miRNAs) are emerging as important regulators of allergic inflammation and potential therapeutic targets. We sought to identify which miRNAs are expressed in CD4(+) T-cells and determine whether allergic stimuli or glucocorticoids alter their expression. Methods: After IRB approval, blood was collected from dust mite (DM) allergic rhinitis subjects (n=20), non-allergic controls (n=8), and asthmatics (n=16). Peripheral blood mononuclear cells were incubated with dust mite extract (DME), diluent control, or DME + dexamethasone (0.1 pM). CD4(+)T-cells were collected by magnetic bead column, and RNA was isolated by guanidinium/phenol-chloroform extraction. MicroRNA expression was measured using Nanostring microarray and quantitative real time PCR (qPCR). Results: We identified 196 miRNAs that were stably expressed in circulating CD4(+) T-cells. Allergen stimulation of CD4(+) T-cells with DME differentially induced miR-155 expression in cells of DM-allergic subjects as compared to non-allergic subjects. Induction of miR-155 expression was also observed with anti-CD3/anti-CD28 simulation and phorbol-12-Myristate-13-Acetate (PMA) treatment, and further augmented by calcium inophore and bromocyclic AMP in the latter treatment. The level of miR-155 expression was positively associated with expression of the T(H)2 cytokines IL-5 and IL-13. Inhibition of miR-155 in Jurkat T-cells inhibited the production of these cytokines. Glucocorticoids attenuated the effects of dust mite allergen, raising the possibility that inhibition of this miRNA could be a mechanism through which glucocorticoids exhibit their anti-inflammatory effects. The CD4(+) T-cells had a higher level of miR-155 expression in asthma compared to in allergic rhinitis and non-asthmatics. The inhibitory effects of glucocorticoids on CD4(+) T-cell miR-155 expression were lost in severe asthmatics. Conclusion: Mir-155 is differentially expressed in allergic T-cells exposed to DM extract compared to in non-allergic cells and it is inhibited by glucocorticoids. MiR-155 may play a role in mediating allergic inflammation in T-cells and could be an anti-inflammatory target of steroids. This pathway may be de-regulated in severe asthma.
- 1 January 2018
- Vol. 7 (4) , 57-+
Effects of allergic stimulation and glucocorticoids on miR-155 in CD4+ T-cells
Rationale: MicroRNAs (miRNAs) are emerging as important regulators of allergic inflammation and potential therapeutic targets. We sought to identify which miRNAs are expressed in CD4(+) T-cells and determine whether allergic stimuli or glucocorticoids alter their expression. Methods: After IRB approval, blood was collected from dust mite (DM) allergic rhinitis subjects (n=20), non-allergic controls (n=8), and asthmatics (n=16). Peripheral blood mononuclear cells were incubated with dust mite extract (DME), diluent control, or DME + dexamethasone (0.1 pM). CD4(+)T-cells were collected by magnetic bead column, and RNA was isolated by guanidinium/phenol-chloroform extraction. MicroRNA expression was measured using Nanostring microarray and quantitative real time PCR (qPCR). Results: We identified 196 miRNAs that were stably expressed in circulating CD4(+) T-cells. Allergen stimulation of CD4(+) T-cells with DME differentially induced miR-155 expression in cells of DM-allergic subjects as compared to non-allergic subjects. Induction of miR-155 expression was also observed with anti-CD3/anti-CD28 simulation and phorbol-12-Myristate-13-Acetate (PMA) treatment, and further augmented by calcium inophore and bromocyclic AMP in the latter treatment. The level of miR-155 expression was positively associated with expression of the T(H)2 cytokines IL-5 and IL-13. Inhibition of miR-155 in Jurkat T-cells inhibited the production of these cytokines. Glucocorticoids attenuated the effects of dust mite allergen, raising the possibility that inhibition of this miRNA could be a mechanism through which glucocorticoids exhibit their anti-inflammatory effects. The CD4(+) T-cells had a higher level of miR-155 expression in asthma compared to in allergic rhinitis and non-asthmatics. The inhibitory effects of glucocorticoids on CD4(+) T-cell miR-155 expression were lost in severe asthmatics. Conclusion: Mir-155 is differentially expressed in allergic T-cells exposed to DM extract compared to in non-allergic cells and it is inhibited by glucocorticoids. MiR-155 may play a role in mediating allergic inflammation in T-cells and could be an anti-inflammatory target of steroids. This pathway may be de-regulated in severe asthma.
- 29 April 2014
- Published by Cambridge University Press (CUP) in Journal of Helminthology
- Vol. 89 (4) , 446-452
Does host immunity influence helminth egg hatchability in the environment?
Transmission success for helminths with free-living stages depends on the ability of eggs and larvae to develop and survive once in the environment. While environmental conditions are often suggested to influence egg phenology and hatching rate, immunity against parasite eggs might also play a role. We examined this hypothesis using the gastrointestinal helminthsTrichostrongylus retortaeformisandGraphidium strigosum, two common infections of the European rabbit. Changes in egg hatching rate and volume were examined in relation to specific antibodies in the serum and bound to eggshells, using eggs shed in host faeces over a 15-week period. Hatching rate was consistently higher forT. retortaeformisthanG. strigosumand no changes were observed between weeks. Egg volume increased forG. strigosumbut decreased forT. retortaeformis. We did find evidence of egg-specific antibody responses and fewer antibodies were bound to eggs ofT. retortaeformiscompared toG. strigosum. Little to no association was found between antibodies and hatchability, or volume, for both helminths. We suggest that host antibodies play a relatively minor role in the egg hatching rate of these gastrointestinal helminths.
- 29 April 2014
- Published by Cambridge University Press (CUP) in Journal of Helminthology
- Vol. 89 (4) , 446-452
Does host immunity influence helminth egg hatchability in the environment?
Transmission success for helminths with free-living stages depends on the ability of eggs and larvae to develop and survive once in the environment. While environmental conditions are often suggested to influence egg phenology and hatching rate, immunity against parasite eggs might also play a role. We examined this hypothesis using the gastrointestinal helminthsTrichostrongylus retortaeformisandGraphidium strigosum, two common infections of the European rabbit. Changes in egg hatching rate and volume were examined in relation to specific antibodies in the serum and bound to eggshells, using eggs shed in host faeces over a 15-week period. Hatching rate was consistently higher forT. retortaeformisthanG. strigosumand no changes were observed between weeks. Egg volume increased forG. strigosumbut decreased forT. retortaeformis. We did find evidence of egg-specific antibody responses and fewer antibodies were bound to eggs ofT. retortaeformiscompared toG. strigosum. Little to no association was found between antibodies and hatchability, or volume, for both helminths. We suggest that host antibodies play a relatively minor role in the egg hatching rate of these gastrointestinal helminths.